CD276 and prostate adenocarcinoma: A higher expression of B7-H3 was observed in head and neck squamous cell carcinoma (HNSCC), CP, prostate adenocarcinoma (PRAD), and glioblastoma (GBM), and among these, CPs show particularly high and homogeneous expression.